Caitlin Raymond: Framing Donor Eligibility as Risk Assessment
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
“Donor infectious disease eligibility sounds straightforward — until it isn’t. I just published a new post for trainees framing donor eligibility as risk assessment, not a checklist — the way boards expect you to understand it and the way it actually works in practice. In this post I cover:
- Why some pathogens get NAT, others don’t.
- Why some are tested once, others every donation.
- Why donor history still matters in the era of ultra-sensitive testing.
If you work in transfusion medicine, blood banking, pathology, or are studying for boards, this one’s meant to connect the dots between regulations, biology, and real-world decisions.”
Title: Board Prep: Overview of Donor Infectious Disease Eligibility
Author: Caitlin Raymond
Read the full article here.
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026